TGF-β1 Tg+ or TGF-β1 Tg− mice were injected intraperitoneally (i.p.) with neutralizing antibodies raised against CD25 (Li et al., 2008 (link); Liu et al., 2010 (link)) or FGF-9 (Li et al., 2008 (link)). For CD25 neutralizing studies, 125 μg of anti-CD25 (Biolegend # 101906) or IgG2b isotype control (Biolegend #400622) was injected on days 4, 7, and 10 of doxycycline administration and mice were sacrificed on day 14. For FGF-9 blocking experiments, 250 μg of anti-FGF-9 (R&D #MAB273) or IgG2A isotype control (R&D #MAB003) were injected on days—1, 2, 5, 8, and 11 of doxycycline administration and mice were sacrificed on day 14.
Free full text: Click here